Genotoxicity assessment of S-equol in bacterial mutation, chromosomal aberration, and rodent bone marrow micronucleus tests.
Intervention studies in man have shown that dietary soy isoflavones may provide certain health benefits. One of the possible reasons for this benefit is that the daidzein contained in soy is converted to S-equol. As part of a drug development program for S-equol, three genotoxicity studies were conducted. The studies comprised bacterial mutation, chromosomal aberration, and in vivo bone marrow micronucleus tests conducted according to Good Laboratory Practices (GLP). No evidence of genotoxic activity was observed in the in vitro tests at concentrations up to those associated with cell toxicity. In addition, no evidence of cytotoxicity or genotoxicity was seen in the rat bone marrow micronucleus test in animals dosed at levels up to the standard limit of 2000 mg/kg. It is concluded that S-equol is not active in the standard battery of genotoxicity assays recommended by the International Conference on Harmonisation (ICH) for registration of new pharmaceuticals. The current results support the further development of S-equol.
Schwen
Richard
R
Ausio Pharmaceuticals, LLC, Cincinnati, OH 45212, USA. rick@ausiopharma.com
Jackson
Richard
R
Proudlock
Raymond
R
D000818:Animals; D001419:Bacteria / Q000187:drug effects / Q000235:genetics*; D001854:Bone Marrow Cells / Q000187:drug effects / Q000648:ultrastructure; D002869:Chromosome Aberrations / Q000187:drug effects*; D060754:Equol; D005260:Female; D007529:Isoflavones / Q000633:toxicity*; D008297:Male; D015162:Micronucleus Tests; D009152:Mutagenicity Tests; D009153:Mutagens / Q000633:toxicity*; D048789:Phytoestrogens / Q000633:toxicity*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012486:Salmonella typhimurium / Q000235:genetics
C007610:4',7-dihydroxy-3,4-dihydroisoflavone; D007529:Isoflavones; D009153:Mutagens; D048789:Phytoestrogens; D060754:Equol; C004742:daidzein